Neurovision Medical Products, Inc. Retains Neurovision Trademark (NuVasive, Inc. Forever Barred From Using Trademark)

Share Article

A Los Angeles federal judge found in favor of Neurovision Medical, by issuing a permanent injunction against NuVasive, forever barring the medical device manufacturer from using the trademark NEUROVISION to promote or sell medical devices in the United States.

The injunction follows a verdict earlier this year handed down by the United States District Court for the Central District of California, Western Division (Case No. 09-CV-6988) in which a jury found that Ventura, California-based Neurovision Medical Products, Inc. is the rightful owner of the NEUROVISION trademark and that NuVasive had been willfully infringing upon Neurovision Medical’s trademark rights. The jury also found clear and convincing evidence in Neurovision Medical's favor that NuVasive had defrauded the United States Patent and Trademark Office by registering the NEUROVISION mark for itself despite knowing of Neurovision Medical’s superior rights in the mark. The jury awarded $30 million.

Following the verdict, the judge ruled in favor of Neurovision Medical by denying NuVasive’s post-trial motions and granting an injunction against the Company. In the judge’s written decision granting the injunction, she found that Neurovision Medical “would suffer irreparable harm absent an injunction” and added that she “has no confidence that in the absence of an injunction, [NuVasive] will stop using the mark.”

About Neurovision Medical:

Neurovision Medical is a surgical device company based in Ventura, California. It was founded in 1985 by Dr. J. Lee Rea, a physician and electrical engineer, who was a pioneer in the field of nerve location and avoidance technology used in surgery. Currently, Neurovision Medical is known for state-of-the-art nerve surveillance technology and continues to develop, market, and distribute such products throughout the United States and abroad. Further information about Neurovision Medical can be found at its website


Any questions or comments about this press release should be directed to Neurovision Medical Products at (805) 477-0655 or contact(at)neurovisionmedical(dot)com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Visit website